Opaleye Management reports acquisition of $8,001.28 in Grace Therapeutics common shares
GRCE•Opaleye Management, a 10% owner of Grace Therapeutics, acquired 4,256 common shares at $1.88 each, bringing indirect holdings through Opaleye, L.P. to 2,948,610 shares.
1. Share purchase
Opaleye Management acquired 4,256 Grace Therapeutics common shares at $1.88 each. Its indirect holdings through Opaleye, L.P. rose to 2,948,610 shares following the purchase.
